Families affected by fetal and neonatal alloimmune thrombocytopenia (FNAIT) report experiencing substantial emotional, physical and financial burdens, according to a qualitative study published recently in AJP Reports.
This exploratory study examined experiences shared during virtual interviews and group sessions involving 10 participants in Cohort 1 (9 female and 1 male) between October 2021 and November 2024 and 12 female participants in Cohort 2 between April and May 2025.
Sign up here to get the latest news, perspectives, and information about FNAITFetal and neonatal alloimmune thrombocytopenia A rare condition in which a mother’s immune system attacks fetal platelets, leading to dangerously low platelet levels before and/or after birth. sent directly to your inbox. Registration is free and only takes a minute.
Participants represented the United States, Canada, the United Kingdom, Australia and the Netherlands. Most had experienced at least 2 FNAIT-affected pregnancies, including 7 of 9 eligible participants in Cohort 1 and 11 of 12 in Cohort 2. Five participants in Cohort 1 and 2 in Cohort 2 had experienced the loss of a baby.
Participants described inconsistent diagnostic experiences, with some receiving a diagnosis within days and others facing weeks of uncertainty. FNAIT was frequently identified after birth when newborns developed bruising, pinpoint skin spots, low platelet counts or bleeding complications.
Some babies initially were suspected of having infections or other blood disorders. In Cohort 2, 7 of 12 participants received a diagnosis after their first pregnancy, 3 after their second and 2 after their third. Two participants reported that their children developed cerebral palsy following intracranial hemorrhageBrain bleed Bleeding inside the fetal brain, also known as an intracranial hemorrhage. In FNAIT, it's often caused by severe thrombocytopenia and can lead to long-term disability or death. , or bleeding inside the skull; one child also had epilepsy, autism and dyslexia.
“These qualitative findings based on the lived experience of parents affected by FNAIT indicate the weight of the emotional, logistical, and financial burden placed on families by the lack of screening, diagnostic inconsistency and delay, clinician knowledge gaps, limited communication across medical care settings, and prolonged treatment schedules,” explained the authors of this study.
Read more about FNAIT testing and diagnosis
Limited medical familiarity with FNAIT left parents feeling responsible for educating health care providers and advocating for appropriate care. Participants described intravenous immunoglobulinIntravenous immunoglobulin A treatment given to pregnant women with a history of FNAIT or known alloantibodies. IVIG reduces the immune reaction against fetal platelets. treatment as exhausting and disruptive, with infusions lasting six to 48 hours and side effects including headaches, nausea, fatigue, rashes and aseptic meningitis. Treatment schedules and travel also complicated employment and childcare. Financial strain was another concern, particularly when insurance did not cover treatment or related expenses.
The condition also affected mental health and decisions about having more children. Participants reported anxiety, depression, post-traumatic stress and persistent fears about their babies’ health. Although 83.3% of participants in Cohort 2 had another child after an affected pregnancy, treatment demands and uncertainty influenced subsequent family planning. Few recalled receiving adequate psychological support or clear information about future pregnancy risks.
The findings point to opportunities to improve care through earlier detection, better screening, provider education and coordinated specialist services. Participants also emphasized individualized treatment guidance, understandable educational materials and stronger mental health and financial support.
Because the study included a small, predominantly White sample recruited through outreach, the findings may not reflect every family’s experience. Nevertheless, addressing these unmet needs could help patients navigate pregnancy with greater confidence, reduce avoidable distress and support informed decisions about future pregnancies.
